2.48 USD
▼-0.11-4.25%
盘后 2.60 0.00%
2026-09-16
市值
$1.98M
市盈率
—
EPS
-12.64
股息率
—
52 周区间
2.45 – 21.75
成交量
22.92K
Beta
1.35
目标价
—
52W 低 2.4552W 高 21.75
价格走势
公司简介
Virax Biolabs Group Limited, a biotechnology company, focuses on immune response detection, T cell immune profiling, and the development of in vitro diagnostic technologies for viral and immune-mediated diseases in the United Kingdom, the United States, and China. The company offers ViraxImmune, a T cell-based immune profiling and diagnostic platform for post-acute infection syndromes, including long COVID, myalgic encephalomyelitis / chronic fatigue syndrome, and post-treatment Lyme disease. It also provides ImmuneSelect, a research-use-only p...